Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of SHR2285 in Healthy Subjects
NCT03769831Phase 1Completed
- Sponsor
- Hengrui
- Start
- Feb 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in thrombosis comparing SHR2285 with Placebo (2 arms). Primary endpoint: Number of subjects with adverse events and serious adverse events. Started Feb 2019; status: completed.
02
Drugs
shr2285
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT03769831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03769831.